Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience

Stella Edström Halling1, Magnus P Söderberg, Ulla B Berg

  • 1Department of Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska Institutet, Karolinska University Hospital, Huddinge, 14186, Stockholm, Sweden. stella.edstrom.halling@ki.se

Insights

Two treatment regimens for severe pediatric nephritis showed similar outcomes. Both corticosteroid, cyclophosphamide, and ACEi/ARB therapy, and ACEi/ARB +/- corticosteroids effectively reduced proteinuria and improved kidney function in Henoch-Schönlein nephritis and IgA nephritis.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Immunology

Background:

  • Severe Henoch-Schönlein nephritis (HSN) and immunoglobulin A nephritis (IgAN) in children can lead to significant kidney damage.
  • Treatment strategies for severe pediatric nephritis vary, necessitating research into their comparative efficacy.

Purpose of the Study:

  • To compare the effectiveness of two distinct treatment regimens in children with severe HSN and IgAN.
  • To evaluate the impact of treatments on renal function, proteinuria, and histological findings.

Main Methods:

  • A cohort of 43 children with severe HSN (24) and IgAN (19) were analyzed.
  • Group A received corticosteroids, cyclophosphamide (CYC-P), and ACE inhibitors/angiotensin receptor blockers (ACEi/ARB).
  • Group B received ACEi/ARB with or without corticosteroids.

Main Results:

  • Both treatment groups showed decreased proteinuria at follow-up.
  • Group A demonstrated increased GFR and a reduced histopathological activity index.
  • Treatment outcomes were comparable between the two groups and did not differ between HSN and IgAN.

Conclusions:

  • Combined therapy with corticosteroids, CYC-P, and ACEi/ARB is effective in improving renal parameters in severe pediatric nephritis.
  • ACEi/ARB therapy, with or without corticosteroids, also shows benefits in reducing proteinuria.
  • Treatment efficacy did not significantly differ between the two regimens or between HSN and IgAN.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...